Form 4: Community Health Systems Executive Chad A. Campbell Reports Stock Transactions

Sentiment:

SEC Form 4


Regional President Chad A. Campbell of Community Health Systems Inc. reports acquisition and disposal of common stock and derivative securities, including performance-based restricted shares and stock options, on March 1, 2025.

Summary

  • Chad A. Campbell, Regional President of Community Health Systems Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 1, 2025, Campbell acquired 10,500 shares of common stock related to performance-based restricted shares vesting at 21% based on performance between 2022 and 2024, forfeiting the remaining 39,500 shares.
  • He also acquired 25,000 shares of common stock with time-vesting restrictions lapsing over three years and acquired 25,000 stock options with an exercise price of $3.01.
  • Additionally, 13,972 shares were disposed of at a price of $3.01.
  • Campbell now beneficially owns 136,815 shares of common stock directly.
  • He also holds various stock options with exercise prices ranging from $2.87 to $10.18 and performance-based restricted shares tied to future performance periods.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While there were acquisitions of stock and options, there was also a disposal of shares and a partial forfeiture of performance-based shares, indicating mixed performance.

Positives

  • Campbell's acquisition of 25,000 shares of common stock demonstrates confidence in the company's future.
  • The granting of 25,000 stock options with an exercise price of $3.01 incentivizes Campbell to improve the company's performance.

Negatives

  • The forfeiture of 39,500 performance-based restricted shares indicates that the company did not fully achieve its performance objectives between 2022 and 2024.
  • The disposal of 13,972 shares at $3.01 could be interpreted negatively by investors.

Risks

  • The vesting of performance-based restricted shares is contingent upon achieving specific financial targets, which may not be met.
  • Fluctuations in the company's stock price could impact the value of Campbell's stock options and restricted shares.
  • Future performance periods may not yield the desired results, leading to further forfeitures of performance-based restricted shares.

Future Outlook

The vesting of future performance-based restricted shares is dependent on the company's performance during the 2023-2025, 2024-2026 and 2025-2027 performance periods.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Comparing Community Health Systems' executive compensation and equity grants to those of its peers, such as HCA Healthcare (HCA) and Tenet Healthcare (THC), would provide valuable context.
  • Analyzing the performance metrics used for vesting performance-based restricted shares against industry benchmarks for EBITDA and revenue growth would offer insights into the rigor of the company's performance goals.
  • Reviewing similar Form 4 filings from executives at comparable companies can reveal trends in insider trading activity and sentiment.

Stakeholder Impact

  • The vesting of performance-based restricted shares is tied to the company's financial performance, which directly impacts shareholder value.
  • Executive compensation practices can influence employee morale and retention.
  • The company's ability to achieve its performance goals affects its relationships with customers, suppliers, and creditors.

Next Steps

  • Monitor the company's performance during the 2023-2025, 2024-2026 and 2025-2027 performance periods to assess the vesting of future performance-based restricted shares.
  • Track Campbell's future trading activity for any significant changes in his holdings.

Key Dates

DateDescription
03/01/2021Date of stock options exercisable, expiring 02/28/2030, exercise price $4.93
03/01/2022Date of stock options exercisable, expiring 02/28/2031, exercise price $8.81
03/02/2022Date performance-based restricted shares originally reported by the Reporting Person.
01/01/2022 12/31/20242022-2024 Performance Period for performance-based restricted shares.
03/01/2023Date of stock options exercisable, expiring 02/29/2032, exercise price $10.18
01/01/2023 12/31/20252023-2025 Performance Period for performance-based restricted shares.
03/01/2024Date of stock options exercisable, expiring 02/28/2033, exercise price $6.15
01/01/2024 12/31/20262024-2026 Performance Period for performance-based restricted shares.
03/01/2025Date of earliest transaction; vesting of performance-based restricted shares; acquisition of common stock and stock options; disposal of shares.
01/01/2025 12/31/20272025-2027 Performance Period for performance-based restricted shares.
03/03/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.